Report

Inhibition of Xenoreactive Natural Antibody Production by Retroviral Gene Therapy

Science  18 Sep 1998:
Vol. 281, Issue 5384, pp. 1845-1847
DOI: 10.1126/science.281.5384.1845

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The major barrier to transplantation across discordant species, such as from pig to human, is rejection mediated by xenoreactive natural antibodies (XNA) that bind the carbohydrate epitope Galα1-3Galβ1-4GlcNAc-R (αGal) on donor tissues. This epitope is synthesized by the enzyme glucosyltransferase uridine 5′-diphosphate galactose:β-d-galactosyl-1,4-N-acetyl-d-glucosaminide α(1-3)galactosyltransferase (E.C. 2.4.1.151), or simply αGT. When a functional αGT gene was introduced by retroviral gene transfer into bone marrow cells, αGal XNA production in a murine model ceased. Thus, genetic engineering of bone marrow may overcome humoral rejection of discordant xenografts and may be useful for inducing B cell tolerance.

  • * To whom correspondence should be addressed. E-mail: iacomini{at}helix.mgh.harvard.edu

View Full Text